ArticleExperimental and therapeutic medicine2026
Hepatic perivascular epithelioid cell tumor: A rare mesenchymal tumor with epithelioid features: A case report.
Article in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms characterized by distinctive histological and immunohistochemical features. The tumor family originally included renal angiomyolipoma and pulmonary clear cell 'sugar' tumor. The present report describes a case of a hepatic PEComa in a 43-year-old man with no comorbidities and otherwise good health, who presented with abdominal discomfort and right upper quadrant tenderness. Laboratory findings were unremarkable. The patient underwent robotic-assisted left hemihepatectomy, and the results indicated negative margins. Histologically, the tumor consisted of epithelioid, polyhedral cells with central to eccentric nuclei and abundant eosinophilic cytoplasm, arranged in nests and separated by a delicate capillary network. Central necrosis was present, closely resembling hepatocellular carcinoma. Immunohistochemistry demonstrated strong expression of Melan-A and HMB-45, focal positivity for smooth muscle actin, and negativity for other lineage markers. The Ki-67 proliferation index was <5%. CD34 immunostaining demonstrated strong positivity in the endothelial cells, thereby highlighting the rich capillary network associated with the tumor. Molecular analysis supported the diagnosis. Next-generation sequencing identified pathogenic variants in TSC2 (exons 10 and 27), while fluorescence
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.